Plain-English translation of ·
The UK Islet Autoantibody Registry is a tracking study for people who have tested positive for special proteins in their blood that signal early stages of Type 1 Diabetes—before symptoms appear. Researchers want to follow participants over time to understand how quickly the disease develops in different people and to identify who might be candidates for new treatments being tested to prevent or delay Type 1 Diabetes.
Type 1 Diabetes can now be detected years before a person gets sick, when certain autoantibodies appear in the blood. This early warning gives doctors a chance to prevent the dangerous, life-threatening complications that can happen when diabetes is diagnosed suddenly. By tracking people with these early markers, researchers hope to learn more about the disease's progression and connect people to prevention trials as they become available.
You likely qualify if…
You likely don't qualify if…
As a participant, you would share your existing blood test results showing that you have tested positive for diabetes autoantibodies. The study may also involve additional blood draws and possibly interviews if you've been living with a positive result for at least 6 months. Researchers will track your health over time to see how your condition develops and may contact you about new prevention trials as they become available.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United Kingdom